Two Cases of Allopurinol Hypersensitivity Syndrome due to Use of Allopurinol for the Patient with Asymptomatic Hyperuricemia.
- Author:
Wan Ik CHO
1
;
Yang Hyun YOON
;
Myeung Nam KIM
;
Seong Jun SEO
;
Chang Kwun HONG
;
Byung In RO
Author Information
1. Department of Dermatology, College of Medicine, Chung-Ang University, Korea. drseo@hanafos.com
- Publication Type:Case Report
- Keywords:
Allopurinol hypersensitivity syndrome;
Asymptomatic hyperuricemia
- MeSH:
Allopurinol*;
Eosinophilia;
Fever;
Giant Cells;
Humans;
Hypersensitivity*;
Hyperuricemia*;
Leukocytosis;
Pneumonia;
Polycystic Kidney Diseases;
Steroids;
Ureter;
Xanthine Oxidase
- From:Korean Journal of Dermatology
2005;43(7):961-964
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Allopurinol (4-hydroxypyrazolo[3, 4-d]pyrimidine) is a xanthine oxidase inhibitor and is widely used in the treatment of hyperuricemia. Allopurinol hypersensitivity syndrome (AHS) includes a prolonged illness initially manifested by fever, a prominent cutaneous reaction, eosinophilia, hepatic abnormalities, and decreased renal function. Two patients in our study had a decreased renal function; one due to bilateral polycystic kidneys and the other due to bilateral ureteral stones. Both had received allopurinol for asymptomatic hyperuricemia. Whilst taking this medication, they showed a generalized erythematous, maculopapular eruption with fever, leukocytosis, eosinophilia, a further decrease of renal function and prolonged severe hepatic abnormalities. One patient showed an improvement after they stopped taking allopurinol and were treated with steroids, however, died, due to combined giant cell pneumonia. However, the other patient did improve when they stopped taking allopurinol.
